Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01372098 · ClinicalTrials.gov registry record · NA
Nurse-family Partnership (NFP) Curriculum Study
A NA study, sponsored by McMaster University.
- Completed
- Registry status
- NA
- Development phase
- 492
- Enrollment target
NCT01372098: Completed NA study, sponsored by McMaster University.
NCT01372098 is a NA study that has completed, run by McMaster University. The registered enrollment target is 492 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (65% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01372098, a NA study, has completed, sponsored by McMaster University.
- COMPLETED
- Registry status
- NA
- Development phase
- 492 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether the Intimate Partner Violence (IPV) intervention in the context of Nurse-Family Partnership (NFP) program improves women's quality of life and reduces violence relative to the NFP alone using a cluster randomized controlled trial. Our hypothesis is that an IPV intervention can be designed that is acceptable to participants in the NFP, feasible to implement, and that this intervention will improve quality of life for women and reduce exposure to violence.
Interventions
- BEHAVIORAL NFP + IPV intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 492 participants |
| Start Date | 2011-05 |
| Est. Completion | 2015-05 |
| Phase | NA |
What the finished NCT01372098 record still lists
NCT01372098 is an interventional study that assigns participants to a tested intervention. The registered 492 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (65% lower).
The record links to 0 conditions, and to 1 intervention - of which NFP + IPV intervention is the first listed.
NCT01372098 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01372098 about?
NCT01372098 is a clinical study titled "Nurse-family Partnership (NFP) Curriculum Study". The purpose of this study is to determine whether the Intimate Partner Violence (IPV) intervention in the context of Nurse-Family Partnership (NFP) program improves women's quality of life and reduces violence relative to the NFP alone using a cluster randomized controlled trial. Our hypothesis is t...
What is the current status of trial NCT01372098?
This trial is currently completed. It is a NA study. The enrollment target is 492 participants. The study started on 2011-05. Estimated completion is 2015-05.
What interventions are being tested in trial NCT01372098?
The interventions under investigation include: NFP + IPV intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT01372098?
This trial is sponsored by McMaster University, which has 31 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01372098's enrollment target sits among peer trials
492 213th of 2000 higher than 1,786 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05861973 · 492 participants · NA
SMARTer Weight Loss Management
- NCT05908331 · 492 participants · NA
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
- NCT06152575 · 492 participants · Phase 3
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
- NCT06953089 · 492 participants · Phase 2
DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia